Metformin for Treatment of Multiple Sclerosis and Graft-versus-host Disease
Metformin prevents the production of reactive oxygen species (ROS) of mitochondrial complex I. Consequently the expression of CD95 (Fas) ligand is blocked leading to the inhibition of activation-induced T-cell death (AICD). Thus undesirable T-cell death can be inhibited by metformin. Therefore metformin can be used for the treatment of T-cell mediated inflammatory diseases like multiple sclerosis and graft-versus-host disease.
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
High-energy-density aqueous battery based on halogen multi-electron transfer
Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…
First-ever combined heart pump and pig kidney transplant
…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…
Biophysics: Testing how well biomarkers work
LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…